The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival and patient-reported outcomes of real-world patients with high-risk stage II and stage III colon cancer after 3 versus 6 months of adjuvant CAPOX.
 
Ingrid A. Franken
No Relationships to Disclose
 
Frederieke H. van der Baan
Research Funding - Personal Genome Diagnostics (Inst)
 
Geraldine R. Vink
Research Funding - Bayer (Inst); BMS Netherlands (Inst); Delfi Diagnostics (Inst); Lilly (Inst); Merck (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); SERVIER (Inst); Sirtex Medical (Inst)
 
Anne Maria May
No Relationships to Disclose
 
Wilhelmina M.U. van Grevenstein
No Relationships to Disclose
 
Miriam Koopman
Research Funding - Bayer (Inst); BMS GmbH & Co. KG (Inst); Merck Serono (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
 
Jeanine Roodhart
Leadership - Foundation Hubrecht Organoid Biobank
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck Serono; Pierre Fabre; SERVIER
Research Funding - Bristol-Myers Squibb (Inst); Cleara Biotech (Inst); HUB Organoids (Inst); Pierre Fabre (Inst); SERVIER (Inst)